W1 (Pyridostigmine Bromide Extended-Release 180 mg)
Pill with imprint W1 is Yellow, Capsule-shape and has been identified as Pyridostigmine Bromide Extended-Release 180 mg. It is supplied by Amneal Pharmaceuticals LLC.
Pyridostigmine is used in the treatment of myasthenia gravis; reversal of nondepolarizing muscle relaxants; nerve agent pretreatment and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W1
Pyridostigmine Bromide Extended-Release
- Imprint
- W1
- Strength
- 180 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinergic muscle stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 00115-1404
Related Images for "W1"
More about pyridostigmine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 35 Reviews
- Drug class: cholinergic muscle stimulants
Consumer resources
- Patient Information
- Pyridostigmine Extended-Release Tablets
- Pyridostigmine Tablets
- Pyridostigmine Injection
- Pyridostigmine Liquid
- Other brands
- Mestinon, Mestinon Timespan, Regonol
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.